As of 2025-07-15, the Fair Value of Nirvana Life Sciences Inc (NIRV.CN) is -0.36 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.10 CAD, the upside of Nirvana Life Sciences Inc is -455.60%.
With the market price of 0.10 CAD and our fair value calculation, Nirvana Life Sciences Inc (NIRV.CN) is not a good investment. Investing in NIRV.CN stocks now will result in a potential loss of 455.60%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-10-31 | 2021-10-31 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 5Y Avg | |
| Net income | -0.31 | -0.25 | -5.65 | -1.49 | -0.87 | -1.72 |
| YoY growth | -2,460.93% | 19.02% | -2,121.87% | 73.70% | 41.38% | -889.74% |
| Market Cap (mil) | 0.48 |
| P/E | |
| Forward P/E |
| EPS | -0.07 |
| Avg earnings growth rate | -889.74% |
| TTM earnings | -0.34 |